Frankie A Holmes

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.

Lajos Pusztai, Christos Sotiriou, Kenneth R Hess, 2007, The Lancet. Oncology.

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

Yuan Qi, Lajos Pusztai, Charles Coutant, 2011, Journal of the National Cancer Institute.

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.

P Kelly Marcom, H. Rugo, B. Overmoyer, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Feasibility assessment of a chemoresponse assay to predict pathologic response in neoadjuvant chemotherapy for breast cancer patients.

F. Holmes, J. O’Shaughnessy, B. Hellerstedt, 2008, Anticancer research.

Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial

Yuan Qi, Nan Song, Kui Shen, 2012, BMC Medical Genomics.